Conscience VC is an early-stage venture capital firm founded in 2020, dedicated to investing in science-driven, consumer-focused companies that aim to empower humanity. The firm primarily focuses on pre-seed and seed-stage investments in sectors such as biotech, healthcare, and wellness. Their investment thesis encompasses a broad range of industries, including cell and gene therapy, precision medicine, epigenetic reprogramming, organoid technology, RNA therapeutics, quantified self, longevity, microbiome health, psychedelics, mental health, autoimmune disease management, women's health, food as medicine, infant health, food security, synthetic biology, reproductive aging, family planning, and early disease detection.